These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36890010)

  • 1. Metabolically healthy obesity: Misleading phrase or healthy phenotype?
    Tanriover C; Copur S; Gaipov A; Ozlusen B; Akcan RE; Kuwabara M; Hornum M; Van Raalte DH; Kanbay M
    Eur J Intern Med; 2023 May; 111():5-20. PubMed ID: 36890010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tirzepatide and potential use for metabolically healthy obesity.
    Copur S; Tanriover C; Yavuz F; Tuttle KR; Kanbay M
    Eur J Intern Med; 2023 Jul; 113():1-5. PubMed ID: 37183081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
    Lonardo A; Mantovani A; Lugari S; Targher G
    Ann Hepatol; 2020; 19(4):359-366. PubMed ID: 32349939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical Activity and Risk of Metabolic Phenotypes of Obesity: A Prospective Taiwanese Cohort Study in More Than 200,000 Adults.
    Martinez-Gomez D; Ortega FB; Hamer M; Lopez-Garcia E; Struijk E; Sadarangani KP; Lavie CJ; Rodríguez-Artalejo F
    Mayo Clin Proc; 2019 Nov; 94(11):2209-2219. PubMed ID: 31619366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children.
    Genovesi S; Antolini L; Orlando A; Gilardini L; Bertoli S; Giussani M; Invitti C; Nava E; Battaglino MG; Leone A; Valsecchi MG; Parati G
    Front Endocrinol (Lausanne); 2020; 11():27. PubMed ID: 32117055
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition.
    Barrea L; Muscogiuri G; Pugliese G; de Alteriis G; Colao A; Savastano S
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between metabolically healthy obesity and metabolically unhealthy obesity by different definitions among Mexican children.
    Evia-Viscarra ML; Guardado-Mendoza R
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):215-222. PubMed ID: 31834862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic abnormalities, but not obesity per se, associated with chronic kidney disease in a Taiwanese population.
    Chen HY; Lu FH; Chang CJ; Wang RS; Yang YC; Chang YF; Wu JS
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):418-425. PubMed ID: 31744713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevalence of Metabolically Healthy and Unhealthy Obesity according to Different Criteria.
    Liu C; Wang C; Guan S; Liu H; Wu X; Zhang Z; Gu X; Zhang Y; Zhao Y; Tse LA; Fang X
    Obes Facts; 2019; 12(1):78-90. PubMed ID: 30814477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity Metabolic Phenotype, Changes in Time and Risk of Diabetes Mellitus in an Observational Prospective Study on General Population.
    Yang C; Liu X; Dang Y; Li J; Jing J; Tian D; Qiu J; Zhang J; Yan N; Liu X; Zhao Y; Zhang Y
    Int J Public Health; 2022; 67():1604986. PubMed ID: 36250153
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolically Healthy Obesity: Criteria, Epidemiology, Controversies, and Consequences.
    Tsatsoulis A; Paschou SA
    Curr Obes Rep; 2020 Jun; 9(2):109-120. PubMed ID: 32301039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive metabolic profiling of the metabolically healthy obesity phenotype.
    Telle-Hansen VH; Christensen JJ; Formo GA; Holven KB; Ulven SM
    Lipids Health Dis; 2020 May; 19(1):90. PubMed ID: 32386512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolically healthy versus unhealthy obese phenotypes in relation to hypertension incidence; a prospective cohort study.
    Hamzeh B; Pasdar Y; Moradi S; Darbandi M; Rahmani N; Shakiba E; Najafi F
    BMC Cardiovasc Disord; 2022 Mar; 22(1):106. PubMed ID: 35287586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Prognosis of Acute Myocardial Infarction Associated With Metabolic Health and Obesity Status.
    Chew NWS; Kong G; Venisha S; Chin YH; Ng CH; Muthiah M; Khoo CM; Chai P; Kong W; Poh KK; Foo R; Yeo TC; Chan MY; Loh PH
    Endocr Pract; 2022 Aug; 28(8):802-810. PubMed ID: 35654337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of systemic endothelial-dependent and endothelial-independent microvascular reactivity in metabolically healthy obesity: An observational study.
    Escobar S; Peçanha D; Duque M; Duque A; Crahim V; De Lorenzo A; Tibirica E
    Microvasc Res; 2023 Jul; 148():104553. PubMed ID: 37230166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Subset of CD95
    Johnson C; Drummer Iv C; Shan H; Shao Y; Sun Y; Lu Y; Saaoud F; Xu K; Nanayakkara G; Fang P; Bagi Z; Jiang X; Choi ET; Wang H; Yang X
    Front Immunol; 2020; 11():619951. PubMed ID: 33488632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes.
    Zhao L; Zou Y; Wu Y; Cai L; Zhao Y; Wang Y; Xiao X; Yang Q; Yang J; Ren H; Tong N; Liu F
    Front Endocrinol (Lausanne); 2023; 14():1103251. PubMed ID: 37234807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
    Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
    PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.